Windtree Therapeutics (WINT) executive Fraser received 45,867 shares
Stocks in this Quantisnow insightHealth Care
Insider transactions reported
Craig Fraser (executive at Windtree Therapeutics Inc., WINT) reported that they received 45,867 shares on Aug 23, 2023. After these transactions the filing shows 52,877 shares held directly.
- Reporting person
- Fraser Craig
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 23, 2023 | Grant or award (A) | Common Stock1 | +45,867 | - | - | 52,877 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Aug 23, 2023 | Grant or award (A) | Employee Stock Option (Right to Buy)On 68,800 Common Stock3 | +68,800 | - | - | 68,800 direct |
Holdings before and after
- Common Stock: 7,010 to 52,877 direct
- Employee Stock Option (Right to Buy): 0 to 68,800 direct
Other positions listed
- Common Stock: 3 indirect, By Trust
Footnotes from the filing
- 1. These shares represent restricted stock units (RSUs), which represent a contingent right to receive the equivalent number of shares of common stock. These RSUs shall vest with respect to one-third of the total number of shares subject to the RSUs on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
- 2. Holding amount represents issuer's matching stock contribution pursuant to 401(k) plan.
- 3. This employee stock option shall vest and become exercisable with respect to one-third of the total number of shares subject to the option on an annual basis (every 12 months) with the first vest date on August 23, 2024 provided that the reporting person remains in continuous service on each vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Fraser report in this WINT Form 4?
Craig Fraser (executive at Windtree Therapeutics Inc., WINT) reported that they received 45,867 shares on Aug 23, 2023. After these transactions the filing shows 52,877 shares held directly.
How many WINT shares does Fraser hold after this filing?
The filing shows 52,877 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for WINT
Earlier insider filings at WINT
- Apr 27, 2023SEC Form 4 filed by Fraser Craig
- Apr 26, 2023SEC Form 4 filed by Fraser Craig
- Mar 3, 2023SEC Form 4: Simonson Steven covered exercise/tax liability with 100 shares, decreasing direct ownership by 6% to 1,573 units
- Mar 3, 2023SEC Form 4: Fraser Craig covered exercise/tax liability with 334 shares, decreasing direct ownership by 7% to 4,198 units
- Mar 3, 2023SEC Form 4: Curtis Eric covered exercise/tax liability with 99 shares, decreasing direct ownership by 7% to 1,253 units
Quantisnow market dataNASDAQ
WINT
Windtree Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
Get push alerts for WINT
Full WINT profile on Quantisnow Follow WINT and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time